Ansell (ASX:ANN) share price falls again amid broker upgrade

It was another disappointing day on the ASX for the maker of gloves and personal protective equipment.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Group of stressful businesspeople having problems. sittong around a desk.

Image source: Getty Images

Key points

  • The Ansell share price fell again today after sinking 14% yesterday
  • Macquarie upgraded the Ansell share price to "neutral" from "underperform"
  • But the modest upside to Macquarie's price target didn't seem to excite investors

The Ansell Limited (ASX: ANN) share price struggled for a second successive day on Tuesday, slipping 0.34% lower by the close of trading.

The personal protective equipment maker's shares were in the red for much of the day save for a couple of spikes before closing at $26.67 apiece. For comparison, the S&P/ASX 200 Index (ASX: XJO) finished up 0.49%.

Today's fall follows a 14% crash in the Ansell share price yesterday when the company released a disappointing trading update.

It also comes despite a top broker upgrading the company's shares.

Ansell share price struggles despite upgrade

The big sell-off yesterday prompted Macquarie Group Ltd (ASX: MQG) to lift its recommendation on Ansell. But this doesn't appear to have been enough to motivate bargain hunters to jump in.

This is likely because Macquarie upgraded the Ansell share price to "neutral" from "underperform". The broker doesn't think the shares have fallen far enough to be considered cheap.

Big earnings miss

While Ansell's 1H FY22 revenue was largely in line with Macquarie's expectations, earnings were nearly 20% under forecasts.

"This reflected impacts due to COVID-19 (reduced labour availability), supply chain constraints (delivery delays, higher freight costs), and weaker demand in Exam/Single Use (customer de-stocking)," said Macquarie.

To make matters worse, Ansell is unable to pass on the higher costs – at least not yet. This resulted in the earnings before interest and tax (EBIT) margin falling to 11% in the half, or 6.5 percentage points below 1H FY21.

Gloves come off for Ansell

What is also hurting Ansell is that its facility in Malaysia was forced to shut due to rising COVID cases. Meanwhile, US authorities have banned the import of disposable gloves from YTY Industry Holdings, a major supplier of gloves for Ansell.

"Combined with an expectation of a continuation of operational challenges/supply chain disruption into 2H22 and preliminary 1H22 results, FY22 guidance has been revised to US125-145 cents, with the mid-point ~27% below the mid-point of previous guidance (US175-195 cents) and ~20% below FactSet consensus," added Macquarie.

What is the Ansell share price worth?

But there is a silver lining. The significant drop in the Ansell share price limits the downside risks to the investment.

"While acknowledging earnings uncertainty for 2H22 and into FY23, we see our revised forecasts as capturing downside risk within Exam/Single Use as well as broader COVID-19/supply chain impacts," explained Macquarie.

The broker's 12-month price target on Ansell is $28.30 a share. This implies an upside of 6%, based on today's closing price.

Ansell shares are down around 30% over the past 12 months and 15% this year to date.

Motley Fool contributor Brendon Lau owns Ansell Ltd. and Macquarie Group Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ansell Ltd. and Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on CBA shares

A leading analyst forecasts headwinds for CBA shares. But why?

Read more »

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Broker reiterates buy ratings on 2 ASX shares

These ASX shares remain worth watching.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

After more than quadrupling investors' money in a year, are PLS shares still a buy?

A leading analyst delivers his outlook for the soaring PLS share price.

Read more »

A young man wearing a bright yellow jumper and glasses purses his lips together and moves them to the side of his face as he wonders about something.
Broker Notes

Buy, hold, or sell? Life360, Iress, Lynas Rare Earths shares

Experts reveal their views.

Read more »